Bendamustine: something old, something new Nishant TagejaJasdeepa Nagi Mini Review 08 April 2010 Pages: 413 - 423
Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance Yong Wha MoonJoo Hyuk SohnJoo-Hang Kim Original Article 15 December 2009 Pages: 425 - 431
GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line Yan LiuKe-Ming XiePing Xie Original Article 24 November 2009 Pages: 433 - 439
A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors E. Gabriela ChioreanSrikar MalireddyChristopher J. Sweeney Original Article 29 November 2009 Pages: 441 - 448
Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer Lian JiangDao-yuan WangDan-feng Wang Original Article 24 November 2009 Pages: 449 - 453
Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines Ying WangArun K. RishiAnil Wali Original Article 04 December 2009 Pages: 455 - 466
Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies Liangao HuWeimin MiaoGerald Batist Original Article 26 November 2009 Pages: 467 - 474
Differential apoptotic response of human cancer cells to organoselenium compounds Maiko SuzukiManabu EndoHidemi Rikiishi Original Article 26 November 2009 Pages: 475 - 484
DNA incorporation of 6-thioguanine nucleotides during maintenance therapy of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma Rikke L. HedelandKristian HvidtKjeld Schmiegelow Original Article 03 December 2009 Pages: 485 - 491
The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer Jun LiangTao JiangWei-wei Qi Original Article 04 December 2009 Pages: 493 - 500
Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy Augusto NogueiraRaquel CatarinoRui Medeiros Original Article 04 December 2009 Pages: 501 - 506
Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status Yeon Hee ParkSoohyeon LeeYoung-Hyuck Im Original Article 03 December 2009 Pages: 507 - 516
Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: implication in oxidative stress Toshiyuki MatsunagaYoshitaka TsujiAkira Hara Original Article 05 December 2009 Pages: 517 - 526
A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer Kohei NakachiJunji FuruseSatoshi Shimizu Original Article 05 December 2009 Pages: 527 - 534
A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells Andrew J. MasseyDouglas S. WilliamsonMike Wood Original Article 13 December 2009 Pages: 535 - 545
Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines Sara NannizziGareth J. VealRomano Danesi Original Article Open access 18 December 2009 Pages: 547 - 558
Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma Fotios LoupakisGianluca MasiAlfredo Falcone Original Article 17 March 2010 Pages: 559 - 566
Anemia response and safety to epoetin-beta treatment in patients with neoadjuvant therapy prior to primary digestive tract tumor surgery Antonio GómezMercedes SalgadoRafael López Original Article 12 December 2009 Pages: 567 - 573
Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells Kathryn E. ReinickeMary J. KuffelMatthew M. Ames Original Article 11 December 2009 Pages: 575 - 583
Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells Seema-Maria NathwaniStephen ButlerDaniela M. Zisterer Original Article 18 December 2009 Pages: 585 - 596
Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment Jiayu WangYing FanBinghe Xu Clinical Trial Report 21 May 2010 Pages: 597 - 603
Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis Mohamed BouchahdaAbdoulaye KarabouéFrancis Lévi Short Communication 02 April 2010 Pages: 605 - 609
The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro Jürgen SonnemannStephanie GreßmannJames F. Beck Short Communication 10 March 2010 Pages: 611 - 616
MDR1 C2005T polymorphism changes substrate specificity Lijuan LiuLan FanHonghao Zhou Short Communication 23 March 2010 Pages: 617 - 623